<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
<title>International Prognostic Index for non-Hodgkin lymphoma</title>
<link href="medcalcstyles.css" type="text/css" rel="stylesheet" />
<meta name="description" content="Medical Calculators, Criteria Sets and Decision Trees" />
<meta name="keywords" content="heme onc, prognosis, medcalc3000, medical, education, criteria, treecalc, decision, tree, medicine, clinical, medcalc, 3000, mdcalc, medicalc, medmath, clinicalc, clincalc, online, clinical" /> 
<meta name="author" content="Foundation Internet Services, LLC" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=no" />
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii" />
</head>
<body class="medCalcBody">
<div id="mc3k">
<script language="JavaScript1.1" type="text/javascript">
/* <![CDATA[ */



var calctxt = '';
var xmltxt = '';
var xmlresult = '';
var htmtxt = '';
var postNow = false;
var printing = false;


function IPINHL_fx() {
with(document.IPINHL_form){

Score = 0.0;
doCalc = true;

if (cc1.checked){
Score = Score + 1;
}
if (cc2.checked){
Score = Score + 1;
}
if (cc3.checked){
Score = Score + 1;
}
if (cc4.checked){
Score = Score + 1;
}
if (cc5[0].checked){
Score = Score + 0; 
}
if (cc5[1].checked){
Score = Score + 0; 
}
if (cc5[2].checked){
Score = Score + 1; 
}
if (cc5[3].checked){
Score = Score + 1; 
}
if (cc5[4].checked){
Score = Score + 1; 
}
if (doCalc){
cctotal.value = Score;
if (cctotal.value == 'NaN') cctotal.value = '';
}
else{
Score = null;
cctotal.value = '';
if (typeof rrclr == 'function') { rrclr(); };
document.IPINHL_form.cctotal.value = '';
}

if (doCalc){
rrclr();
if (( Score >= 0) && ( Score <= 1)){ document.getElementById('rr1_1').bgColor = '#cccccc';
}
if (( Score >= 2) && ( Score <= 2)){ document.getElementById('rr1_2').bgColor = '#cccccc';
}
if (( Score >= 3) && ( Score <= 3)){ document.getElementById('rr1_3').bgColor = '#cccccc';
}
if (( Score >= 4) && ( Score <= 5)){ document.getElementById('rr1_4').bgColor = '#cccccc';
}
if ((Score >= 0) && (Score <= 1)){ document.getElementById('rr2_5').bgColor = '#cccccc';
}
if ((Score >= 2) && (Score <= 2)){ document.getElementById('rr2_6').bgColor = '#cccccc';
}
if ((Score >= 3) && (Score <= 3)){ document.getElementById('rr2_7').bgColor = '#cccccc';
}
if ((Score >= 4) && (Score <= 5)){ document.getElementById('rr2_8').bgColor = '#cccccc';
}


}
}
}




function rrclr(){
document.getElementById('rr1_1').bgColor = '';
document.getElementById('rr1_2').bgColor = '';
document.getElementById('rr1_3').bgColor = '';
document.getElementById('rr1_4').bgColor = '';
document.getElementById('rr2_5').bgColor = '';
document.getElementById('rr2_6').bgColor = '';
document.getElementById('rr2_7').bgColor = '';
document.getElementById('rr2_8').bgColor = '';
}




/* ]]> */
</script>



<form name="IPINHL_form" id="IPINHL_form" action="" onsubmit="return false;" onreset="rrclr(); ">
<table width="100%" cellpadding="4" cellspacing="0" summary="EBMcalc Table">
<tr><td class="medCalcTitleBox" width="1%"><br /></td>
<td class="medCalcTitleBox">
<span class="medCalcFontTitleBox">

 
International Prognostic Index for non-Hodgkin lymphoma
</span></td></tr></table><br />&nbsp;<br />
<div id="calc_main">
<div id="calc_input">
<center>
<table cellpadding="3" cellspacing="0" summary="EBMcalc Table">
<tr><td width="20"><br /></td>
<td align="right" valign="top"><input type="checkbox" name="cc1" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontCCTab">Age &gt;60 years old (1 point)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right" valign="top"><input type="checkbox" name="cc2" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontCCTab">Serum lactate dehydrogenase concentartion above normal (1 point)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right" valign="top"><input type="checkbox" name="cc3" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontCCTab">Ann Arbor stage III or IV (1 point)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right" valign="top"><input type="checkbox" name="cc4" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontCCTab">More than one extranodal disease site (1 point)</span></td></tr>
<tr><td colspan="3" align="left"><span class="medCalcFontCCTabBold">ECOG performance scale </span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontCCTab"> Performance status 0: Fully active; no performance restrictions (0 points)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontCCTab"> Performance status 1: Strenuous physical activity restricted; fully ambulatory and able to carry out light work (0 points)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontCCTab"> Performance status 2: Capable of all self-care but unable to carry out any work activities. Up and about &gt;50 percent of waking hours (1 point)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontCCTab"> Performance status 3: Capable of only limited self-care; confined to bed or chair &gt;50 percent of waking hours (1 point)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontCCTab"> Performance status 4: Completely disabled; cannot carry out any self-care; totally confined to bed or chair (1 point)</span></td></tr>

</table>
</center>
</div>
<br />&nbsp;<br />
<div id="calc_result">
<span class="medCalcFontCCTabBold">
Total Criteria Point Count:
</span>
<input type="text" size="6" name="cctotal" onfocus="blur();" /><br />&nbsp;<br />
<center><input type="reset" name="reset" value="Reset Form" />    </center>
<br />&nbsp;<br />
<table width="100%" cellpadding="4" cellspacing="0" summary="EBMcalc Table">
<tr><td class="medCalcTitleBox" width="1%"><br /></td>
<td class="medCalcTitleBox">
<span class="medCalcFontTitleBox">

 When applied to a group of 2031 patients with aggressive non-Hodgkin lymphoma treated with anthracycline-based regimens  that did NOT include rituximab, 5 year overall survival (OS) and complete response (CR) rates were as follows:
</span></td></tr></table><br />&nbsp;<br />
<center>
<table border="1" cellpadding="4" cellspacing="0" summary="RRTable">
<tr id="rr1_1"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">0 to 1 point:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne">Low risk with 73% 5 year OS and 87% CR</span></td></tr>
<tr id="rr1_2"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">2 points:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> Low-intermediate risk with 51% 5 year OS and 67% CR</span></td></tr>
<tr id="rr1_3"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">3 points:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> High-intermediate risk with 43% 5 year OS and 55% CR</span></td></tr>
<tr id="rr1_4"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">4 to 5 points:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> High risk with 26% 5 year OS and 44% CR</span></td></tr>

</table>
</center>
<br />&nbsp;<br />
<br />&nbsp;<br />
<table width="100%" cellpadding="4" cellspacing="0" summary="EBMcalc Table">
<tr><td class="medCalcTitleBox" width="1%"><br /></td>
<td class="medCalcTitleBox">
<span class="medCalcFontTitleBox">

 When applied to 1063 patients treated with rituximab plus CHOP/CHOP-like chemotherapy, 3 year event-free survival (EFS),  progression free survival (PFS) and complete response (CR) rates were as follows:
</span></td></tr></table><br />&nbsp;<br />
<center>
<table border="1" cellpadding="4" cellspacing="0" summary="RRTable">
<tr id="rr2_5"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">0 to 1 point:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> EFS 81%, PFS 87% and OS 91%</span></td></tr>
<tr id="rr2_6"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">2 points:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> EFS 69%, PFS 75% and OS 81%</span></td></tr>
<tr id="rr2_7"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">3 points:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> EFS 53%, PFS 59% and OS 65%</span></td></tr>
<tr id="rr2_8"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">4 to 5 points:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> EFS 50%, PFS 50% and OS 59%</span></td></tr>

</table>
</center>
<br />&nbsp;<br />

</div>
</div>

<div id="calc_notes">
<span class="medCalcFontOneBold">Notes</span>
<ul class="medCalcFontOne">
<li><b>ECOG</b>: Eastern Cooperative Oncology Group</li>
<li><b>NHL</b>: Non-Hodgkin lymphoma</li>

</ul>
</div>

<br />&nbsp;<br />

<div id="calc_refs">
<span class="medCalcFontRef"><b>References</b></span>
<ol>
<li><span class="medCalcFontRef">The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive  non-Hodgkin's lymphoma. <i>N Engl J Med</i>. 1993 Sep 30;329(14):987-94. PubMed ID: 8141877 <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed/8141877"><img border="0" src="pubmed.gif" align="top" alt="PubMed Logo" /></a> </span></li>
<li><span class="medCalcFontRef">Ziepert M, Hasenclever D, Kuhnt E, et al. Standard International prognostic index remains a valid  predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. <i> J Clin Oncol</i>. 2010 May 10;28(14):2373-80. Epub 2010 Apr 12. Erratum in: J Clin Oncol. 2011 Feb 20;29(6):779. PubMed ID: 20385988 <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed/20385988"><img border="0" src="pubmed.gif" align="top" alt="PubMed Logo" /></a> </span></li>
<li><span class="medCalcFontRef">Oken MM, Creech RH, Tormey DC, et al., Eastern Cooperative Oncology Group, Robert Comis M.D., Group Chair.  Toxicity and response criteria of the Eastern Cooperative Oncology Group. <i> Am J Clin Oncol</i>. 1982 Dec;5(6):649-55. PubMed ID: 7165009 <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed/7165009"><img border="0" src="pubmed.gif" align="top" alt="PubMed Logo" /></a> </span></li>

</ol>
</div>

 
</form>
<div id="calc_disclaimer"><br />&nbsp;<br /><center><br />&nbsp;<br />&nbsp;<br /><table bgcolor="#cccccc" cellpadding="16" summary="EBMcalc Table"><tr><td><center><span class="medCalcFontTwo"><b><u>Legal Notices and Disclaimer</u></b></span></center><br />&nbsp;<br /><span class="medCalcFontTwo">All information contained in and produced by the EBMcalc system is provided
for educational purposes only. This information should not be used for the 
diagnosis or treatment of any health problem or disease.
<b>THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR
GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.
</b><a href="disclaimer-en.htm" target="_blank">Click here for full notice and disclaimer.</a></span><br />&nbsp;<br /><center><span class="medCalcFontTwo">EBMcalc is Copyright &#169; 1998-2018 Foundation Internet Services &nbsp;&nbsp; [Build 255633 v18.3]</span></center></td></tr></table></center>
</div><script language="JavaScript1.1" type="text/javascript">
/* <![CDATA[ */



IPINHL_fx();

/* ]]> */
</script>



</div>
</body>
</html>


<!-- 1532964227 //-->
